Add Yahoo as a preferred source to see more of our stories on Google. logos of OpenAI Anadolu via Getty Images There’s interesting news coming from Sam Altman’s empire, a firm known for innovating as ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

Google rolled out a brand new experimental AI tool last Thursday called Project Genie. By Friday, video game stocks were tumbling as a result. Gaming industry giants like Unity Software, Roblox, ...

Martin County Sheriff John Budensiek on Jan. 22, 2026, discusses baby formula theft following the arrest of two people reportedly found with $8,000 worth of the product. Watch the Somerset College ...

Following the success of TikTok and Instagram Reels, Disney announced that it’s bringing short-form video content to Disney+ in the U.S. this year in a bid to boost daily engagement. Disney made the ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Next year is going to be a big one for Formula 1. For the first time in quite a while there will be 11 teams on the grid, including new comers Audi and Cadillac. Ford and Honda are also returning as ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

Beyonce and Jay-Z were among the celebrities in attendance Saturday night at the Las Vegas Street Circuit to watch the 2025 Las Vegas Grand Prix. Formula 1 shared a video of the stars greeting Ferrari ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...